Sec. 402. Fertility treatment benefits
195 words·~1 min read·
/bill/118/s/4445/pcs/section-402·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 8904 of title 5, United States Code, is amended— in subsection (a)— in paragraph (1), by adding at the end the following: Fertility treatment benefits. ; and in paragraph (2)— by redesignating subparagraph
(F)as subparagraph (G); and by inserting after subparagraph
(E)the following: Fertility treatment benefits. ; and by adding at the end the following: In this section, the term fertility treatment includes the following: Preservation of human oocytes, sperm, or embryos for later reproductive use. Artificial insemination, including intravaginal insemination, intracervical insemination, and intrauterine insemination. Assisted reproductive technology, including in vitro fertilization and other treatments or procedures in which reproductive genetic material, such as oocytes, sperm, fertilized eggs, and embryos, are handled, when clinically appropriate. Genetic testing of embryos. Medications prescribed or obtained over-the-counter, as indicated for fertility. Gamete donation. Such other information, referrals, treatments, procedures, medications, laboratory services, technologies, and services relating to fertility as the Director of the Office of Personnel Management, in coordination with the Secretary of Health and Human Services, determines appropriate. . The amendments made by this section shall take effect on the date that is 1 year after the date of enactment of this Act.